| No Glaucoma (N=32482) |
Glaucoma (N=7049) |
P-value | |
|---|---|---|---|
| Sex | |||
| Male | 12705 (39.1%) | 3249 (46.1%) | <0.001 |
| Female | 19777 (60.9%) | 3800 (53.9%) | |
| Race | |||
| White | 19163 (59.0%) | 3837 (54.4%) | <0.001 |
| Black | 7165 (22.1%) | 1903 (27.0%) | |
| Asian | 345 (1.1%) | 120 (1.7%) | |
| Hispanic | 4879 (15.0%) | 981 (13.9%) | |
| Other | 930 (2.9%) | 208 (3.0%) | |
| Age (y) | |||
| Mean (SD) | 61.5 (13.4) | 69.3 (11.3) | <0.001 |
| Median [Min, Max] | 62.8 [21.7, 91.3] | 70.9 [20.6, 91.2] | |
| Diabetes | |||
| No Diabetes | 9184 (28.3%) | 3832 (54.4%) | <0.001 |
| Diabetes | 23298 (71.7%) | 3217 (45.6%) | |
| Education Level | |||
| Less than a high school degree or equivalent | 2943 (9.1%) | 538 (7.6%) | <0.001 |
| High School or GED | 6849 (21.1%) | 1241 (17.6%) | |
| College 1-3 years | 10622 (32.7%) | 2081 (29.5%) | |
| College graduate or advanced degree | 12068 (37.2%) | 3189 (45.2%) | |
| Income | |||
| <$50k | 19339 (59.5%) | 3745 (53.1%) | <0.001 |
| $50k-$100k | 7438 (22.9%) | 1797 (25.5%) | |
| $100k-$150k | 3225 (9.9%) | 798 (11.3%) | |
| $150k-$200k | 1179 (3.6%) | 310 (4.4%) | |
| >$200k | 1301 (4.0%) | 399 (5.7%) | |
| Medication | |||
| Bupropion | 9417 (29.0%) | 728 (10.3%) | <0.001 |
| GLP Agonist | 2700 (8.3%) | 151 (2.1%) | |
| Naltrexone | 706 (2.2%) | 38 (0.5%) | |
| None | 17734 (54.6%) | 6029 (85.5%) | |
| Orlistat | 208 (0.6%) | 23 (0.3%) | |
| Sympathomimetic | 1717 (5.3%) | 80 (1.1%) |